PNP Therapeutics is a biopharmaceutical company engaged in the development of platform technology and proprietary products for the treatment of cancer. It offers patented enzyme E. coli purine nucleoside phosphorylase working with a variety of nucleoside prodrugs generating active metabolites with anti-tumor activity.